ARCH Venture Management, LLC
Top Portfolio Positions
10 positions ·
$677,097,730 total
· as of Mar 31, 2026
| Ticker | Company | Shares | Value (USD) | % of Portfolio | Open |
|---|---|---|---|---|---|
| MAZE |
Maze Therapeutics, Inc.
Healthcare
|
4,120,053 | $122,983,582 | 18.16% | |
| RAPP |
Rapport Therapeutics, Inc.
Healthcare
|
3,728,738 | $116,672,212 | 17.23% | |
| VIR |
Vir Biotechnology, Inc.
Healthcare
|
12,916,663 | $115,733,300 | 17.09% | |
| ERAS |
Erasca, Inc.
Healthcare
|
7,091,557 | $114,741,392 | 16.95% | |
| BEAM |
Beam Therapeutics Inc.
Healthcare
|
4,540,132 | $108,191,345 | 15.98% | |
| LYEL |
Lyell Immunopharma, Inc.
Healthcare
|
3,247,162 | $65,138,069 | 9.62% | |
| GENB |
Generate Biomedicines, Inc.
Healthcare
|
1,944,426 | $24,305,325 | 3.59% | |
| TXG |
10x Genomics, Inc.
Healthcare
|
217,834 | $4,624,615 | 0.68% | |
| GOSS |
Gossamer Bio, Inc.
Healthcare
|
8,055,916 | $2,650,396 | 0.39% | |
| QTTB |
Q32 Bio Inc.
Healthcare
|
320,482 | $2,057,494 | 0.30% |
Portfolio Trend
20 quarters · across all stocks
Holdings in RAPP
Shares Held
Position Value (USD)
8 quarters on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $116,672,212 | 3,728,738 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $113,129,910 | 3,728,738 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $110,743,518 | 3,728,738 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $42,395,751 | 3,728,738 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $37,399,242 | 3,728,738 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $66,147,812 | 3,728,738 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $76,364,554 | 3,728,738 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $86,730,445 | 3,728,738 | Shares | Sole | 2024-08-14 | |
| No 13F history on record for this holder in this stock. | ||||||